Betta Pharmaceuticals Co Ltd

300558.SZ

$5.33

Closing

▲0.91%

1D

▼-25.02%

YTD

Market cap

$2.23B

52 week high

$10.09

52 week low

$4.57

Volume

9,784,535

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$2.23B

Analysts' Rating

BUY

Price Target (Mean)

0.00

Total Analysts

1

P/E

41.38

Operating Margin

20.64%

Beta

1.47

Revenue Growth (Annual)

-

52 week high

$10.09

52 week low

$4.57

Div. Yield

0.18%

EPS Annual Growth

0.00

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

Betta Pharmaceuticals Co Ltd is a company mainly engaged in research, development, production and sales of innovative drugs for the treatment of malignant tumors. The Company’s primary product is its self-developed icotinib hydrochloride (Conmana), a small molecule targeted anticancer drug used for the treatment of lung cancer. The Company is also engaged in promotional services, real estate leasing and other businesses.